biotech · Chronic Hepatitis B · Chronic Hepatitis B Infection · ALGS
Aligos Therapeutics
Aligos Therapeutics clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1 Corporate Dr, South San Francisco, California 94080, US
- Founded
- 2018
- Employees
- 98
- Programs
- 14
- Drugs
- 10
- Patents
- 32
Aligos Therapeutics projects
14 ClinicalTrials.gov programs sponsored by Aligos Therapeutics.
Aligos Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ALG-000184
Aligos Therapeutics
Chronic Hepatitis B Infection
1 trial -
ALG-000184-202
Aligos Therapeutics
Chronic Hepatitis B Virus Infection
1 trial -
ALG-055009
Aligos Therapeutics
NASH
1 trial -
ALG-000184
Aligos Therapeutics
Chronic Hepatitis B
1 trial -
ALG-010133
Aligos Therapeutics
Chronic Hepatitis B
1 trial -
ALG-020572
Aligos Therapeutics
Chronic Hepatitis B
1 trial -
ALG-055009
Aligos Therapeutics
NASH - Nonalcoholic Steatohepatitis
1 trial -
ALG-055009
Aligos Therapeutics
Healthy Volunteer Study
1 trial -
ALG-097558
Aligos Therapeutics
COVID-19
3 trials -
ALG-125755
Aligos Therapeutics
Chronic Hepatitis B
1 trial -
Atorvastatin
Aligos Therapeutics
Healthy Volunteers
1 trial -
Carbamazepine
Aligos Therapeutics
Healthy Volunteer
1 trial -
Pevifoscorvir Sodium (ALG-000184)
Aligos Therapeutics
Chronic Hepaititis B Infections
1 trial -
Pevifoscorvir Sodium (ALG-000184)
Aligos Therapeutics
Chronic Hepatitis B Infection
1 trial
Frequently asked questions
How many clinical projects does Aligos Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.